PLC-XD1, or Phosphatidylinositol-specific Phospholipase C X Domain Containing 1, is a protein that plays a role in lipid signaling pathways within the cell. The protein is encoded by the gene PLCXD1 and belongs to the phospholipase family of enzymes, which are involved in the hydrolysis of phospholipids into fatty acids and other lipophilic substances.
Phospholipase C (PLC) enzymes are critical for generating second messengers from phosphatidylinositol 4,5-bisphosphate (PIP2), a phospholipid found in the cell membrane. Upon activation, PLC enzymes cleave PIP2 to produce diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3), two important secondary messengers that propagate intracellular signals. DAG remains in the membrane and can activate certain types of protein kinase C (PKC), while IP3 is released into the cytoplasm, where it can increase intracellular calcium levels by binding to IP3 receptors on the endoplasmic reticulum.PLC-XD1, however, differs from the classical PLC enzymes as it lacks the catalytic domain typically responsible for the hydrolysis of PIP2. The exact function of PLC-XD1 is not entirely understood, but it is believed to be involved in the regulation of cellular processes through its interactions with other proteins and lipids, possibly influencing the activity of other PLC isoforms or participating in alternative signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate and activate PLC-XD1, enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, potentially enhancing PLC-XD1 activity through calcium-dependent mechanisms. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises cAMP levels, which may lead to the activation of a PKA-dependent pathway enhancing PLC-XD1 activity. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
GTPγS is a non-hydrolyzable GTP analog that can activate G-proteins, potentially leading to the activation of PLC-XD1. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium inhibits inositol monophosphatase leading to higher inositol triphosphate (IP3) levels, possibly enhancing PLC-XD1 function. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $27.00 $35.00 | 20 | |
Neomycin binds to phosphoinositides, potentially freeing up substrates for enhanced PLC-XD1 activity. | ||||||
ET-18-OCH3 | 77286-66-9 | sc-201021 sc-201021A sc-201021B sc-201021C sc-201021F | 5 mg 25 mg 50 mg 100 mg 1 g | $111.00 $436.00 $843.00 $1576.00 $3756.00 | 6 | |
Edelfosine can modulate lipid signaling pathways that may lead to the activation of PLC-XD1. | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
ET-18-OCH3 interferes with phospholipid metabolism, possibly leading to increased PLC-XD1 activity. | ||||||